Multiple sclerosis is the most common chronic inflammatory disease of the central nervous system and it is the leading cause of neurological disability in young adults. Fingolimod Hydrochloride is the first oral drug approved by the USFDA for the treatment of multiple sclerosis, but as of now very few methods is available to determine the drug instrumentally. This book is aiming to address that gap with vivid methodology proper explanation & description. An effort has been made to focus on the way of doing method development & validation according to official agencies (ICH) guidelines in maximum parameter along with all figures & tables. This book is written in lucid manner, so this book is must have for students who are pursuing masters & bachelor degree in Pharmacy or Analytical Chemistry or any other related courses. Researcher in this field & even company personnel analysing this type of drug will find this book very help full. More over in this book a detail description of method development & description of UV- Visible spectroscopy is also included. Wish happy reading to all readers.
Die Inhaltsangabe kann sich auf eine andere Ausgabe dieses Titels beziehen.
Somsubhra Ghosh is Assistant Professor in the Department of Pharmaceutical Analysis & Quality Assurance in Nalanda College of Pharmacy, Hydrabad. He has written 2 books & 30 papers in different reputed National & International Journals. He has also spent 8 years in different Pharmaceutical companies. He has participated in different conferences.
„Über diesen Titel“ kann sich auf eine andere Ausgabe dieses Titels beziehen.
Anbieter: preigu, Osnabrück, Deutschland
Taschenbuch. Zustand: Neu. UV-VIS Method development of Fingolimode Hcl | Somsubhra Ghosh (u. a.) | Taschenbuch | 56 S. | Englisch | 2014 | LAP LAMBERT Academic Publishing | EAN 9783659570407 | Verantwortliche Person für die EU: preigu GmbH & Co. KG, Lengericher Landstr. 19, 49078 Osnabrück, mail[at]preigu[dot]de | Anbieter: preigu. Artikel-Nr. 105149777
Anzahl: 5 verfügbar